The COVID-19 outbreak has resulted in uncertainty for patients with autoimmune rheumatic diseases for several reasons. They are concerned about their risk of developing COVID-19 as many are immune suppressed from their disease and/or treatment whether they should stop their advanced therapies if they will have a worse outcome if/when infected due to their underlying medication conditions and if they will have drug availability especially with press without much data coverage suggesting hydroxychloroquine may be used in COVID-19 infection causing diversion of medication supply. This article discusses how the pandemic affects people with systemic autoimmune rheumatic diseases. What Does the COVID-19 Pandemic Mean for Rheumatology Patients?